These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35002677)

  • 1. Enhanced Contractive Tension and Upregulated Muscarinic Receptor 2/3 in Colorectum Contribute to Constipation in 6-Hydroxydopamine-Induced Parkinson's Disease Rats.
    Zhang XL; Zhang XH; Yu X; Zheng LF; Feng XY; Liu CZ; Quan ZS; Zhang Y; Zhu JX
    Front Aging Neurosci; 2021; 13():770841. PubMed ID: 35002677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats.
    Zhang X; Li Y; Liu C; Fan R; Wang P; Zheng L; Hong F; Feng X; Zhang Y; Li L; Zhu J
    Transl Res; 2015 Aug; 166(2):152-62. PubMed ID: 25766133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats.
    Fornai M; Pellegrini C; Antonioli L; Segnani C; Ippolito C; Barocelli E; Ballabeni V; Vegezzi G; Al Harraq Z; Blandini F; Levandis G; Cerri S; Blandizzi C; Bernardini N; Colucci R
    J Pharmacol Exp Ther; 2016 Feb; 356(2):434-44. PubMed ID: 26582732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired nitrergic relaxation in pyloric sphincter of the 6-OHDA Parkinson's disease rat.
    Fan YY; Zhang Y; Fan RF; Wang T; Yu X; Zheng LF; Zhu JX
    Am J Physiol Gastrointest Liver Physiol; 2022 Jun; 322(6):G553-G560. PubMed ID: 35380456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model.
    Colucci M; Cervio M; Faniglione M; De Angelis S; Pajoro M; Levandis G; Tassorelli C; Blandini F; Feletti F; De Giorgio R; Dellabianca A; Tonini S; Tonini M
    Auton Neurosci; 2012 Aug; 169(2):77-86. PubMed ID: 22608184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.
    Zheng LF; Wang ZY; Li XF; Song J; Hong F; Lian H; Wang Q; Feng XY; Tang YY; Zhang Y; Zhu JX
    Brain Res; 2011 Oct; 1420():59-67. PubMed ID: 21955729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of β1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease.
    Song J; Zheng L; Zhang X; Feng X; Fan R; Sun L; Hong F; Zhang Y; Zhu J
    Transl Res; 2014 Jul; 164(1):22-31. PubMed ID: 24467967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced acetylcholine and elevated muscarinic receptor 2 in duodenal mucosa contribute to the impairment of mucus secretion in 6-hydroxydopamine-induced Parkinson's disease rats.
    Yan JT; Liu XY; Liu JH; Li GW; Zheng LF; Zhang XL; Zhang Y; Feng XY; Zhu JX
    Cell Tissue Res; 2021 Nov; 386(2):249-260. PubMed ID: 34370080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of nerve pathways mediating colorectal dysfunction in Parkinson's disease model produced by lesion of nigrostriatal dopaminergic neurons.
    Chai XY; Diwakarla S; Pustovit RV; McQuade RM; Di Natale M; Ermine CM; Parish CL; Finkelstein DI; Furness JB
    Neurogastroenterol Motil; 2020 Sep; 32(9):e13893. PubMed ID: 32512642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in descending brain-spinal pathways regulating colorectal motility in a rat model of Parkinson's disease.
    Sawamura T; Yuki N; Aoki K; Horii K; Horii Y; Naitou K; Tsukamoto S; Shiina T; Shimizu Y
    Am J Physiol Gastrointest Liver Physiol; 2024 Feb; 326(2):G195-G204. PubMed ID: 38111988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
    Levandis G; Balestra B; Siani F; Rizzo V; Ghezzi C; Ambrosi G; Cerri S; Bonizzi A; Vicini R; Vairetti M; Ferrigno A; Pastoris O; Blandini F
    Neurogastroenterol Motil; 2015 Dec; 27(12):1783-95. PubMed ID: 26433214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Antonioli L; Colucci R; Tirotta E; Gentile D; Ippolito C; Segnani C; Levandis G; Cerri S; Blandini F; Barocelli E; Ballabeni V; Bernardini N; Blandizzi C; Fornai M
    Neuropharmacology; 2017 Sep; 123():22-33. PubMed ID: 28526609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
    Karasawa H; Pietra C; Giuliano C; Garcia-Rubio S; Xu X; Yakabi S; Taché Y; Wang L
    Neurogastroenterol Motil; 2014 Dec; 26(12):1771-82. PubMed ID: 25327342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra.
    Zheng LF; Song J; Fan RF; Chen CL; Ren QZ; Zhang XL; Feng XY; Zhang Y; Li LS; Zhu JX
    Acta Physiol (Oxf); 2014 Jun; 211(2):434-46. PubMed ID: 24410908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide-S prevents 6-OHDA-induced gastric dysmotility in rats.
    Sinen O; Özkan A; Ağar A; Bülbül M
    Brain Res; 2021 Jul; 1762():147442. PubMed ID: 33753063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Fornai M; Colucci R; Tirotta E; Blandini F; Levandis G; Cerri S; Segnani C; Ippolito C; Bernardini N; Cseri K; Blandizzi C; Haskó G; Antonioli L
    J Neuroinflammation; 2016 Jun; 13(1):146. PubMed ID: 27295950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.
    Zhu HC; Zhao J; Luo CY; Li QQ
    J Mol Neurosci; 2012 May; 47(1):15-25. PubMed ID: 21647710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats.
    Naitou K; Nakamori H; Shiina T; Ikeda A; Nozue Y; Sano Y; Yokoyama T; Yamamoto Y; Yamada A; Akimoto N; Furue H; Shimizu Y
    J Physiol; 2016 Aug; 594(15):4339-50. PubMed ID: 26999074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons.
    Bu J; Qiao X; He Y; Liu J
    Life Sci; 2019 Aug; 231():116581. PubMed ID: 31220524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.